Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CyanConnode gets big order from IntelliSmart

(Sharecast News) - Narrowband radiofrequency and smart mesh network technology specialist CyanConnode announced receiving an order for 265,331 Omnimesh modules from Madhyanchal One Infrastructure on Monday, a subsidiary of IntelliSmart Infrastructure. The AIM-traded firm said the order included advanced metering infrastructure (AMI), standards-based hardware, services, Omnimesh head-end software, a perpetual licence, and an annual maintenance contract.

It said the procurement was geared towards facilitating a new smart metering deployment for Madhyanchal Vidyut Vitaran Nigam (MVVNL) - a utility entity situated in Lucknow, India.

The board said the order was the fifth under a strategic framework agreement initiated last February.

It said the delivery of Omnimesh Modules for the project was set to start in the first quarter of, with all hardware supply expected to conclude during 2025.

Furthermore, a support and maintenance contract would extend for seven and a half years post the project's go-live phase.

"We are delighted to announce a fifth order from IntelliSmart received under the strategic framework agreement," said executive chairman John Cronin.

"CyanConnode's influence in India continues to grow as the nationwide rollout of smart meters gains momentum.

"This order takes our cumulative order book for India to 6.6 million Omnimesh modules, of which we have successfully delivered 2.8 million modules by the end of the 2024 financial year."

At 0945 BST, shares in CyanConnode were up 1.73% at 7.88p.

Reporting by Josh White for Sharecast.com,

Share this article

Related Sharecast Articles

Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.
Aptitude inks three-year deal with US insurance brokerage
(Sharecast News) - Financial software solutions provider Aptitude Software announced a significant contract win with a prominent multibillion-dollar insurance brokerage in the United States on Monday.
Picton Property reports solid asset management progress
(Sharecast News) - Picton Property Income announced significant developments in its asset management strategy on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.